Big Pharma paid off public health official to push useless TPOXX drug for monkeypox that DOESN’T WORK

09/30/2024 / By Ethan Huff

Former New York City “Covid czar” Dr. Jay Varma did a whole lot more bad things than just engage in wild, drug-addled sex parties during the Wuhan coronavirus (Covid-19) “pandemic,” the world has recently learned.

The latest news to drop from Steven Crowder, who broke the story via his “Mug Club,” is that Dr. Varma took cash payments from a drug company called SigaTech in exchange for pushing that company’s monkeypox drug “TPOXX” that does not even work.

In the video below, watch as Dr. Varma explains how the corporate media had a role to play in creating the “spin” surrounding TPOXX that SigaTech hoped would stop investors from “dumping” the company’s “worthless” stock.

Even though monkeypox, also known as mpox, is a gay disease that spreads through perversion, Dr. Varma’s job was to help scare the general public into begging for TPOXX.

“We want the Food and Drug Administration, the FDA, to approve our drug specifically for Monkeypox and right now it’s only considered experimental and they won’t approve it based on this study,” Dr. Varma says in the video.

“We also need to keep up the people’s belief that the [TPOXX] drug works. So, that’s why spinning it in the media is helpful.”

BREAKING: NYC’s Covid Orgy Kingpin Reveals He Was Hired by Pharmaceutical Company @SigaTech to Help Sell Monkeypox Drug ‘TPOXX’; Details Media “Spin” Scheme To Ensure Investors Don’t “Dump” Company’s “Worthless” Stock; Says Disease Primarily Impacting Gay Community is Not a… pic.twitter.com/TJpzVHAlRn

— Steven Crowder (@scrowder) September 25, 2024

(Related: After telling New Yorkers to avoid human contact for their own “safety,” Dr. Varma participated in a drug-fueled orgy – because politicians are above the law.)

SigaTech’s biggest client is Washington

Perhaps unsurprising is the fact that SigaTech’s number-one customer is none other than the federal government, which purchases drugs from the company primarily for smallpox.

“They have secured hundreds of millions of dollars [sic] worth of contracts over the years,” Crowder tweeted.

As of Aug. 21, 2024, SigaTech has successfully secured not one, not two, but three separate procurement contracts for TPOXX, all of which were forged in the past three years. The Department of Defense (DOD) is paying $9 million to SigaTech as part of the deal.

“Now it appears, SIGA wants to use TPOXX to cash in on the Monkeypox hype – and according to Varma, needs the FDA to approve its Emergency use to do so even though the studies didn’t turn out the way they wanted,” Crowder warns.

Since SigaTech is a publicly traded company, investors are already responding by selling the company’s stock, which plunged by nearly 20 percent over the past five days since these revelations started gaining traction.

Perhaps the worst thing about all this is the fact that TPOXX does not even work as claimed. It failed in trials to help patients overcome the illness, especially those with other preexisting illnesses.

“One thing we do know is that the antiviral utterly failed in people with untreated HIV and very low CD4 cells, indicating severe immunosuppression,” tweeted Benjamin Ryan, a mainstream media health and science reporter who says SigaTech had trouble recruiting participants.

“Many of these people died agonizing deaths from mpox infection despite multiple TPOXX rounds and an infection that ran for months before killing them, according to a paper in The Lancet last year.”

? VarmaGate Part 2: Monkeypox Media Spin | Alex Jones Infowars to be Liquidated https://t.co/iKBH8Y2Lbw

— Steven Crowder (@scrowder) September 25, 2024